by John Conrad | May 12, 2025 | Policy News
“The President’s Most Favored Nation proposal represents a catastrophic misstep for American biosciences innovation and patient access to life-saving treatments,” said John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization. “This...
by John Conrad | Jun 17, 2024 | iBIO News
John F. Crowley is a man on a mission. As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a unique blend of personal passion and professional expertise to...
by John Conrad | Jun 4, 2024 | NewsBrief
Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered in Taiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory located in the suburbs of Chicago. The strategic move, finalized on June 3, 2024, aims to...
by John Conrad | May 31, 2024 | NewsBrief
A groundbreaking technology developed by researchers at Southern Illinois University Carbondale could help solve two major global issues at once – food insecurity and plastic waste accumulation. Their system, called μBites, can convert biomass and plastic waste...
by John Conrad | Mar 5, 2020 | iBIO News
The Life Sciences Community is Leading the Charge in Fight Against the Coronavirus. iBIO’s resource center provides updated information from the CDC on the spread of COVID-19, best practices to reduce the spread, community risk assesments, prevention and treatment and...
